• Mashup Score: 0
    Have you finished your session proposal? - 1 year(s) ago

    Just a Few Days Remaining to Wrap Up Your Proposals! Submissions close Monday, February 20 at 11:59 PM ET! It’s time for you to put the finishing touches on your scientific session proposals and submit them for consideration to the HFSA Annual Scientific Meeting, taking place October 6-9, 2023 in Cleveland, Ohio. This is your opportunity to be a part of the core scientific programming for…

    Source: contentsharing.net
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of AndrewJSauer
      AndrewJSauer

      Have you finished your session proposal? ⁦@HFSA⁩ ⁦@noshreza⁩ ⁦@mpsotka⁩ https://t.co/1uNYVd9irk

  • Mashup Score: 0
    Top Articles of 2022 - 1 year(s) ago

    1. TOPAZ-1: Overall Survival Prolonged With First-Line Immunotherapy Plus Chemotherapy in Biliary Tract Cancer For the first time, a phase III study has shown an overall survival benefit for upfront treatment using immunotherapy plus chemotherapy in advanced biliary tract cancer. In the TOPAZ-1…

    Source: contentsharing.net
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of RManochakian
      RManochakian

      🚨🔥The 10 most read #articles of @ASCOPost in 2022. Great educational articles on practice changing #Trials & one on @NCCN updates. It’s an #EraOfHope for #Patients with #Cancer. @OncoAlert Remember @ASCO tagline: #KnowledgeConquersCancer 👇🏼 https://t.co/AfDzHbEk7G https://t.co/qITFwr2g5F

  • Mashup Score: 0
    2022 FDA Approvals of Drugs for Cancer Treatment - 1 year(s) ago

    Over the past year, the U.S. Food and Drug Administration (FDA) granted approval to many novel drugs and new indications for older therapeutic agents used in oncology and hematology. Here is a comprehensive list of FDA approvals as of December 22, 2022. ❖ December …

    Source: contentsharing.net
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of FilipJankuMD
      FilipJankuMD

      Quite a number of @US_FDA approvals in oncology in 2022 https://t.co/qeRdzpy2Hj

  • Mashup Score: 0
    2022 FDA Approvals of Drugs for Cancer Treatment - 1 year(s) ago

    Over the past year, the U.S. Food and Drug Administration (FDA) granted approval to many novel drugs and new indications for older therapeutic agents used in oncology and hematology. Here is a comprehensive list of FDA approvals as of December 22, 2022. ❖ December …

    Source: contentsharing.net
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of RManochakian
      RManochakian

      🚨🔥Comprehensive list of all #CancerDrugs approvals & new indications by @US_FDA in 2022 with concise summaries in this very useful article @ASCOPost @ASCO It’s an #EraOfHope for #Patients with #Cancer. 🤞🤞More to come! @OncoAlert 👇🏼 https://t.co/ihDEmxlSOZ https://t.co/tdDzuKH3QR

  • Mashup Score: 1
    2022 PREP SA Nov e-alert - 1 year(s) ago

    Question #77 from 2022 PREP Self-Assessment A previously healthy, 22-month-old girl is brought to the emergency department in January with a 3-day history of high fever, runny nose, cough, and decreased feeding. On physical examination, she has a temperature of 39.1°C, heart rate of 141 beats/min, respiratory rate of 48…

    Source: contentsharing.net
    Categories: Latest Headlines, Pediatrics
    Tweet Tweets with this article
    • Profile photo of AAPSOPT
      AAPSOPT

      It’s @AAP Member Value Monday! Did you know @AAPSOPT members get discounted rates on PREP materials? Try our board prep question here and see for yourself! https://t.co/XHvouMgKO9 https://t.co/HAq8iZt23C

  • Mashup Score: 5
    ASM 2022 - Daily Attendee Email #4 (Day 3) - 2 year(s) ago

    Welcome to Day 3! The program begins today at 6:45 AM EST. Look below for the latest news, overview of sessions, and other exciting details! Plan Your Day: Schedule Highlights Sunday Plenary Late Breaking Clinical Trials Late Breaking Clinical Trials is an always-popular session where speakers present…

    Source: contentsharing.net
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HFSA
      HFSA

      It’s Day 3 at #HFSA2022! Lots of sessions to choose from this morning, but we're sure you'll enjoy whichever one you choose. Read the daily newsletter for details! >> https://t.co/VDNaptXzpa Schedule available in the Virtual Platform or Mobile App: https://t.co/lTjxM2vsyj https://t.co/PCXDoB7kAT

  • Mashup Score: 0
    ASM 2022 - Daily Attendee Email #3 (Day 2) - 2 year(s) ago

    Welcome to Day 2! The program begins today at 6:45 AM EST. Look below for the latest news, overview of sessions, and other exciting details! Plan Your Day: Schedule Highlights Presidential Plenary and Opening Keynote Address Opening Keynote Address: The Importance of Innovation in Heart Failure: Perspectives…

    Source: contentsharing.net
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HFSA
      HFSA

      Welcome to #HFSA2022 Day 2! We're diving right in w/ morning sessions: ✅1 Contemporary Forum ✅2 Roundtable Discussions in the Professionals in Training PIT Lounge ✅1 Satellite Symposia Read the daily newsletter for details! >> https://t.co/yq1BkqMnrY https://t.co/Dy6LhpPkfn

  • Mashup Score: 0
    Join the Heart Failure Research Network - 2 year(s) ago

    The Heart Failure Research Network (HFRN) brings together heart failure researchers interested in clinical trials to advance research, treatments, and patient outcomes.  As an HFSA member, you can join the HFRN and become part of a growing multidisciplinary community of heart failure researchers making an impact for the heart failure field and patients! Are you one of the 200+ HFRN…

    Source: contentsharing.net
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of AndrewJSauer
      AndrewJSauer

      Join the Heart Failure Research Network. ⁦@coconnormd⁩ ⁦@HFSA⁩ https://t.co/R4nRfvjVAA

Load More